CS MEDICA announce extended product availability together with Kronan Apotek in Sweden

CS MEDICA A/S (”CS MEDICA” or the ”Company”) announces today, October 4, that the Company’s purchase agreement together with Kronan Droghandel Apotek AB (“Kronans Apotek”) will now also include product sales of their Cannasen® CBD product line in 326 local pharmacies in Sweden.

CS MEDICA is a Danish medico cannabis company that envisions playing a central role in ensuring the best treatments within healthcare and wellness for patients, healthcare professionals, and consumers around the world. The Company fulfills this purpose by introducing and providing the most effective and innovative OTC cannabinoid products.

Following the Company’s strategy of expanding its market shares, the Company aims to finalize distributor agreements outside of Denmark. Currently, the Company is in the process of entering markets across various nations in Europe. One of the ongoing order discussions regards the purchase and resale agreement with Kronans Apotek in Sweden. As of March 17, 2021, the Company has a purchase agreement with Kronans Apotek covering Cannasen® CBD Arthritis gel & Cannasen® CBD Psoriasis Gel.

Kronans Apotek is currently selling the products in their webshop. In accordance with the purchase agreement, the products are entering the shelf of the 326 local pharmacies of Kronans Apotek as of today, October 4.  The completion of this purchase agreement and fast track sales in Sweden will increase sales and distribution to meet financial targets. The Forecasted market value of treatment products containing CBD in Sweden is estimated to reach 0.5 billion euros in 2028. This purchase agreement not only increases sales and distribution but also helps CS MEDICA expand its market shares and brand visibility in Sweden.

This press release contains inside information that CS MEDICA A/S is required to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication on October 4, 2021 at 13:19 CEST.

For more information about CS MEDICA, please contact:

Lone Henriksen, CEO
Phone: + (45) 71 20 30 47

Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product  manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

Tags:

Subscribe

Documents & Links

Quick facts

CANNASEN® now on shelf in 326 pharmacies in Sweden (Kronan Apotek)
Tweet this